Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x100px

News > All

Total search results: 5334 | Ordered by Date (descending)
1 2 3 ... 52 53 54  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Traceless Materials GmbH. (9/25/23). "Press Release: Traceless Materials Secures €36.6 Million Series A to Build First Industry Plant for Bio-circular Alternative to Plastic". Hamburg. 2023-09-25
Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad. 2023-09-25
Transimmune AG. (9/20/23). "Press Release: Transimmune Secures $5m Funding to Enhance mRNA Vaccination with Novel Dendritic Cell Therapy". Düsseldorf. 2023-09-20
Merck KGaA. (9/20/23). "Press Release: Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery [Not intended for US-, Canada- or UK-based media]". Darmstadt. 2023-09-20
Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. 2023-09-20
BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London. 2023-09-20
BeiGene, Ltd.. (9/19/23). "Press Release: BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody Tevimbra (tislelizumab)". Basel & Beijing & Cambridge, MA. 2023-09-19
Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. 2023-09-19
Galapagos N.V.. (9/19/23). "Press Release: Galapagos Appoints Simon Sturge to Its Board of Directors". Mechelen. 2023-09-19
Lonza Group AG. (9/18/23). "Press Release: Board Announcement. CEO Pierre-Alain Ruffieux to Leave Lonza – Albert M. Baehny to Step in as CEO ad interim". Basel. 2023-09-18
Atriva Therapeutics GmbH. (9/18/23). "Press Release: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology". Tübingen & Martinsried. 2023-09-18
Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan. 2023-09-18
Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. 2023-09-18
Scinai Immunotherapeutics Ltd.. (9/15/23). "Press Release: Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering". Jerusalem. 2023-09-15
SHS Gesellschaft für Beteiligungsmanagement mbH. (9/13/23). "Press Release: Healthcare Specialist SHS Capital Announces Final Closing of Its Oversubscribed Sixth Fund Generation Totaling EUR 270 Million". Tübingen. 2023-09-13
Merck KGaA. (9/12/23). "Press Release: Merck Appoints Axel Löber as Head of Global Communications and Stakeholder Engagement". Darmstadt. 2023-09-12
Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel. 2023-09-11
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. 2023-09-11
Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA. 2023-09-07
Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona. 2023-09-06
Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. 2023-09-06
Scinai Immunotherapeutics Ltd.. (9/6/23). "Press Release: BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics". Jerusalem. 2023-09-06
inContAlert GmbH. (9/6/23). "Press Release: Disruption in the Field of Incontinence. MedTech Startup inContAlert Raises EUR 1.5 Million". 2023-09-06
Oncgnostics GmbH. (9/5/23). "Press Release: Hong Kong Firm Invests in Jena-based Oncgnostics GmbH". Jena. 2023-09-05
Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna. 2023-09-05
iOmx Therapeutics AG. (9/5/23). "Press Release: iOmx Therapeutics Appoints Dr. Nils Peter Debus as Chief Business Officer". Martinsried. 2023-09-05
BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". 2023-09-04
Bayer AG. (8/30/23). "Press Release: Strong Commitment to Modern Crop Protection Made in Europe. Bayer to Invest EUR 220 Million in New R&D Facility at Its Monheim Site". Monheim. 2023-08-30
Intellegens Ltd.. (8/30/23). "Press Release: Intellegens and CPI Awarded £1.6m Innovate UK Grant to Advance Manufacture of Oligonucleotide Therapeutics with Machine Learning". Cambridge. 2023-08-30
Bayer AG. (8/29/23). "Press Release: Gene Editing – Pairwise and Bayer Start New Five-year Multi-million Dollar Collaboration to Further Advance Short-stature Corn". Durham, NC & Monheim. 2023-08-29
T-Curx GmbH. (8/28/23). "Press Release: T-Curx GmbH Announces Appointment of Two Industry Leaders to Its Board of Directors". 2023-08-28
Eppendorf SE. (8/25/23). "Press Release: Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency". San José, CA & Hamburg. 2023-08-25
Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim. 2023-08-23
AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal. 2023-08-23
Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. 2023-08-23
BlueRock Therapeutics LP. (8/23/23). "Press Release: BlueRock’s Phase I Study with Bemdaneprocel in Patients with Parkinson’s Disease Meets Primary Endpoint". Wuppertal. 2023-08-23
Sophia Genetics S.A.. (8/22/23). "Press Release: Sophia Genetics Expands Relationship with Gustave Roussy". Boston, MA & Rolle. 2023-08-22
Bayer AG. (8/22/23). "Press Release: Bayer Appoints Dr. Juergen Eckhardt as New Head of Pharmaceuticals Business Development & Licensing / Open Innovation". Berlin. 2023-08-22
Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". 2023-08-21
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". 2023-08-21
Mysthera Therapeutics AG. (8/21/23). "Press Release: Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies". Basel. 2023-08-21
Pieris Pharmaceuticals, Inc.. (8/17/23). "Press Release: Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific". Boston, MA. 2023-08-17
BioNTech SE. (8/17/23). "Press Release: BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer". Tübingen & Boston, MA. 2023-08-17
CureVac N.V.. (8/17/23). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update". Tübingen & Boston, MA. 2023-08-17
Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA. 2023-08-17
Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen. 2023-08-17
BiondVax Pharmaceuticals Ltd.. (8/11/23). "Press Release: BiondVax Reports Second Quarter Financial Results and Provides Business Update". Jerusalem. 2023-08-11
Bactolife A/S. (8/8/23). "Press Release: Bactolife Raises EUR 30 Million in Series A Financing". Copenhagen. 2023-08-08
Lena Biosciences, Inc.. (8/7/23). "Press Release: Lena Biosciences Appoints Dr. Eckhard von Keutz to Its Business Advisory Board and Science Advisory Board". 2023-08-07
Helmholtz Zentrum München (Helmholtz Munich). (8/7/23). "Press Release: Life Science Factory to Open a New Location at Helmholtz Munich in 2024". Göttingen & Munich. 2023-08-07
Bico Group AB. (8/3/23). "Press Release: Bico Divests Berlin Property for a Total of EUR 21m". 2023-08-03
Sartorius AG. (8/3/23). "Press Release: Florian Funck Appointed CFO of Sartorius. New CFO to Take Over as of April 2024". Göttingen. 2023-08-03
Temedica GmbH. (8/2/23). "Press Release: Temedica and AbbVie Germany Are Launching Digital Companion for Patients with Chronic Inflammatory Bowel Diseases". 2023-08-02
High-Tech Gründerfonds Management GmbH. (8/1/23). "Press Release: Bind-X Secures €10 Million in Financing as Part of Its Series B Financing Round". Martinsried. 2023-08-01
Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. 2023-07-26
AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg. 2023-07-26
IZB Martinsried. (7/25/23). "Press Release: Viopas Venture Consulting Opens Office in the Innovation and Start-up Center Biotechnology (IZB)". Martinsried. 2023-07-25
Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. 2023-07-24
Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel. 2023-07-24
Life Science Factory Management GmbH. (7/24/23). "Pressemitteilung: Tatjana Kasper wird neue Geschäftsführerin". Göttingen. 2023-07-24
Epigenomics AG. (7/24/23). "Press Release: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets". Berlin. 2023-07-24
Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge. 2023-07-24
Biotechnologie Rheinland-Pfalz (MWG RLP). (7/21/23). "Pressemitteilung: Biotechnologie-Studie. Biotechnologie hat in Rheinland-Pfalz sehr gute Zukunft - Bis 2026 stehen bis zu 800 Millionen Euro bereit". 2023-07-21
Idorsia Ltd.. (7/21/23). "Press Release: Idorsia Announces a Cost Reduction Initiative to Be Implemented by the End of 2023". Allschwil. 2023-07-21
Tillotts Pharma AG. (7/20/23). "Press Release: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis". Montréal, Munich & Rheinfelden. 2023-07-20
Idorsia Ltd.. (7/20/23). "Press Release: Idorsia Sells Its Asia Pacific (ex-China) Operations – Including Select License Rights to Products – to Sosei Heptares for a Total Consideration of CHF 400 Million". Allschwil. 2023-07-20
ADC Therapeutics S.A.. (7/20/23). "Press Release: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients". Lausanne. 2023-07-20
LimmaTech Biologics AG. (7/20/23). "Press Release: LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth". Schlieren. 2023-07-20
Novartis AG. (7/20/23). "Press Release: Sandoz Announces Plans to Build a Biosimilar Technical Development Center in Slovenia to Support Future Growth of Biosimilar Pipeline". Basel. 2023-07-20
LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren. 2023-07-20
Biotheus Inc.. (7/19/23). "Press Release: Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech". Zhuhai. 2023-07-19
Sophia Genetics S.A.. (7/19/23). "Press Release: Sophia Genetics Supports Sofiva Genomics to Launch New HRD Test". Boston, MA & Rolle. 2023-07-19
BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam. 2023-07-19
Yumab GmbH. (7/19/23). "Press Release: Yumab and InScreeneX in Joint Funding Project". Braunschweig. 2023-07-19
Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. 2023-07-18
Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich. 2023-07-18
Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. 2023-07-18
SGS S.A.. (7/18/23). "Press Release: SGS Appoints Géraldine Picaud as New Chief Financial Officer [Ad hoc announcement pursuant to Art. 53 LR]". 2023-07-18
AATec Medical GmbH. (7/17/23). "Press Release: AATec Medical Announces Its Launch with EUR 2.7 Million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin". Munich. 2023-07-17
Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel. 2023-07-17
CureVac N.V.. (7/14/23). "Press Release: CureVac Announces Update to the Management Team". Tübingen & Boston, MA. 2023-07-14
High-Tech Gründerfonds Management GmbH. (7/14/23). "Press Release: Pioneering Research Projects at the 8th Life Science Pitch Day at the IZB". Martinsried. 2023-07-14
BioGeneration Ventures B.V.. (7/13/23). "Press Release: BioGeneration Ventures Closes BGV Fund V at €150 Million". Naarden. 2023-07-13
Merck KGaA. (7/12/23). "Press Release: Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA". Darmstadt. 2023-07-12
SparingVision S.A.S.. (7/12/23). "Press Release: SparingVision Sells Ex Vivo GIRK Technology to Tenpoint Therapeutics". Paris. 2023-07-12
Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London. 2023-07-12
High-Tech Gründerfonds Management GmbH. (7/12/23). "Press Release: Vertama Raises Seven-figure Seed Funding for Efficient, Digital Healthcare Processes". Berlin. 2023-07-12
Mallia Therapeutics GmbH. (7/11/23). "Press Release: Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation". Erlangen. 2023-07-11
Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad. 2023-07-11
Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg. 2023-07-11
ECBF Management GmbH. (7/11/23). "Press Release: Aphea.Bio, a Portfolio Company of VC Fund ECBF, Raises a Groundbreaking Series C Round of 70 Million Euros". Luxembourg. 2023-07-11
Zhejiang Doer Biologics Co., Ltd.. (7/10/23). "Press Release: Doer Biologics Announces License Agreement with BioNTech". Hangzhou. 2023-07-10
AiCuris Anti-infective Cures AG. (7/6/23). "Press Release: AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients". Wuppertal. 2023-07-06
TolerogenixX GmbH. (7/6/23). "Press Release: TolerogenixX Expands Phase II Immune-tolerance Trial and Closes EUR 12 million Series A Financing". 2023-07-06
BellaSeno GmbH. (7/6/23). "Press Release: BellaSeno Granted Market Access in Europe for Custom-made Bone and Pectus Excavatum Scaffolds". 2023-07-06
Numaferm GmbH. (7/6/23). "Press Release: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides". 2023-07-06
Golgi Neurosciences S.r.l.. (7/5/23). "Press Release: Golgi Neurosciences, a Unique Incubator to Combat Neurodegenerative Disorders, Starts Operating". Milan. 2023-07-05
Cellbox Solutions GmbH. (7/5/23). "Press Release: Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program". 2023-07-05
NorthX Biologics. (7/3/23). "Press Release: NorthX Biologics, a Leading Nordic Development and Manufacturing Organisation Announces Acquisition of a Biologics Manufacturing Unit from Valneva". Matfors. 2023-07-03
1 2 3 ... 52 53 54  next pagenext page


Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top